Kane Biotech was preparing the annual financial statements and, as part of the year-end procedures, assessed the assets and prepared the following alphabetized schedule based on adjusted values at December 31, 2020: (Do not round intermediate calculations. Round final answers to nearest whole dollar.) Asset Equipment Furniture Land office building Warehouse Date of Purchase May 1/15 Jun. 28/15 Apr. 5/15 Apr. 5/15 Apr. 5/15 Deprec. Method Unita DDB N/A SL SL Cost $ 62,000 29,000 102,000 111,000 80, 500 Residual Value $ 3,710 3,700 N/A 32,300 27,000 Useful Life 8,700 units 8 yrs N/A 15 yrs 20 yrs Accum. Deprec. $ 38,190 24,299 N/A 38,300 29,938 Recoverable Amount S 6, 710 5,450 118,800 69,500 62, 100 -27 *DDB = Double-declining-balance; SL = Straight-line; Units = Units-of-production: N/A = Not applicable Required: 1. Record any impairment losses at December 31, 2020. Assume Kane Biotech has recorded no impairment losses in previous years. View transaction list Journal entry worksheet Record impairment loss on PPE, if any. 3 10 points 2. Record depreciation for each asset at December 31, 2021. Assume that there was no change in the residual values or useful lives regardless of any impairment losses that might have occurred. The equipment produced 2,650 units during 2021 X 032757 View transaction list Skopped Journal entry worksheet pen > 1 2 3 4 Record the revised depreciation on equipment